A 42-year-old woman with chronic corticosteroid use (prednisolone 15 mg daily for autoimmune thyroiditis) undergoes elective cholecystectomy. On postoperative day 10, the surgical incision shows delayed epithelialization with pale, friable granulation tissue. There is no purulent drainage or fever. What is the most appropriate next step in wound management?

Explanation

## Impaired Wound Healing in Chronic Corticosteroid Use ### Pathophysiology of Corticosteroid-Induced Wound Healing Delay **Key Point:** Chronic corticosteroid use impairs all phases of wound healing through multiple mechanisms: - **Inflammatory phase:** Suppressed neutrophil recruitment and macrophage function - **Proliferative phase:** Reduced fibroblast proliferation and collagen synthesis - **Remodeling phase:** Decreased angiogenesis and tensile strength This patient's pale, friable granulation tissue on POD 10 is **characteristic of impaired proliferation**, not infection. ### Why Nutritional Optimization Is the Best Next Step **High-Yield:** Nutritional deficiencies are **compounded by corticosteroid use** and directly impair wound healing. Addressing these is the most evidence-based intervention: | Nutrient | Role in Wound Healing | Corticosteroid Effect | |----------|----------------------|----------------------| | **Protein** | Collagen synthesis, immune function | Increased catabolism | | **Vitamin C** | Collagen cross-linking, angiogenesis | Reduced absorption | | **Zinc** | Fibroblast proliferation, epithelialization | Increased urinary loss | | **Iron** | Collagen hydroxylation | Malabsorption | **Clinical Pearl:** Perioperative corticosteroid management is critical. Patients on chronic corticosteroids require **stress-dose supplementation** (typically doubling the dose) during major surgery and tapering postoperatively. This patient may have been underdosed perioperatively, contributing to impaired healing. ### Management Algorithm for Corticosteroid-Related Wound Impairment ```mermaid flowchart TD A[Delayed wound healing on chronic corticosteroids]:::outcome --> B{Infection present?}:::decision B -->|Yes: fever, purulence| C[Treat infection + optimize steroids]:::action B -->|No: pale granulation, no systemic signs| D[Optimize nutrition & corticosteroid dosing]:::action D --> E[Protein 1.5-2g/kg/day]:::action D --> F[Vitamin C 500-1000 mg daily]:::action D --> G[Zinc 15-30 mg daily]:::action E --> H[Serial assessment POD 14-21]:::decision F --> H G --> H H -->|Healing progressing| I[Continue supportive care]:::outcome H -->|Stalled healing| J[Consider temporary steroid increase or taper plan]:::action ``` ### Why Other Options Are Inappropriate **Silver sulfadiazine** (Option 0) is an antimicrobial agent for infected or at-risk wounds. This wound shows no signs of infection (no fever, no purulence); antimicrobial therapy is not indicated and may delay healing. **Surgical re-exploration and primary closure** (Option 2) is contraindicated in a wound with impaired healing. Premature closure risks dehiscence and abscess formation. The wound should be allowed to heal secondarily with optimized conditions. **Fluoroquinolone antibiotics** (Option 3) are not indicated without clinical or microbiologic evidence of infection. Prophylactic antibiotics in a clean, non-infected wound promote resistance without benefit. ### Supportive Measures **Mnemonic: CHOP** — **C**orticosteroid optimization, **H**ypernutrition, **O**ptimal dressing (moist, non-adherent), **P**atient education (avoid tension, smoking cessation) [cite:Sabiston Textbook of Surgery Ch 6; Harrison 21e Ch 297]